Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-08

Clinical Trial Update: Folic Acid Clinical Trial for the Prevention of Cervical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating folic acid for the prevention of cervical cancer, including precancerous cervical lesions, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • folic acid (folic acid)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Cervical Cancer, Precancerous Condition | Phase 2 | Status: COMPLETED